Health
Metformin use reduces risk of death for patients with COVID-19 and diabetes, study finds – Science Daily
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.”This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive…
-
General18 hours agoIran’s currency at record low as tensions run high
-
Noosa News23 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
General22 hours agoTwo groups of men evicted from Rabbitohs and Roosters NRL clash after wild brawl
-
Noosa News21 hours agoAbusive bus driver fired by council loses appeal